Back to search

Spain· ES:80902

FOSFOMICINA ABAMED 2 G GRANULADO PARA SOLUCION ORAL EN SOBRES EFG

A fosfomycin product containing fosfomicina, registered in Spain by Abamed Pharma S.L.. The same ATC class is registered in 17 of our 19 countries.

ATC J01XX01

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedFOSFOMICINA ABAMED 2 G GRANULADO PARA…ATCJ01XX01REGISTER NO.ES:80902PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Fosfomycin is registered in 17 of 19 countries.

Countries holding a registration under ATC J01XX01 (fosfomycin), each read from that country’s own register.

  • This record: Spain, from AEMPS CIMA (Spain)
  • 10 of them publish a price we can compare per daily dose

Fosfomycin · ATC J01XX01

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fosfomycin costs, country by country.

Normalised to the WHO defined daily dose (3 g), the median price runs from $3.86 in Spain to $16.40 in Switzerland — a ×4.2 gap.

  • Spain: $3.86 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Fosfomycin · price per daily dose (3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$16.40
  • ES Spain$3.86
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

AEMPS CIMA (Spain)
Active substance
fosfomicina
Manufacturer
Abamed Pharma S.L.
Country
Spain (ES)
ATC code
J01XX01
ATC class
Fosfomycin
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cima_codigo
    710978
    1
    EUR 2.26
  • cima_codigo
    710979
    2
    EUR 4.4

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for fosfomycin.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fosfomycin · interactions on record

3 records

  • 2 moderate
  • 1 minor

Most severe, free to view

  • Sodium picosulfateA06AB08moderate
  • BalsalazideA07EC04moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fosfomycin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fosfomycin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Cystium, Fomicyt
  • Belgium · Fomicyt, Fosfomycin Ab
  • Bulgaria · Монурал, Фосфосептик
  • Czechia · Fomicyt, Rapidnorm
  • Germany · Afosfol, Fosfomycin Al
  • Denmark · Fosfomycin Infectopharm, Monurol
  • Estonia · Fosfomycin Sandoz, Uridoz
  • Finland · Fosfomycin Infectopharm, Monuril
  • France · Fomicyt I.V., Fosfomycine Adultes Cristers
  • United Kingdom (Northern Ireland) · Alexi, Fomicyt
  • Greece · Fomicyt, Fosfocin
  • Croatia · Fomicyt, Urifos
  • Hungary · Afosfol, Fomicyt
  • Ireland · Fomicyt, Fosfomycin Ascend
  • Iceland · Monuril
  • Italy · Berny Adulti, Dafocist Adulti
  • Lithuania · Fosfomycin Zentiva, Foziflum
  • Luxembourg · Monuril
  • Latvia · Foziflum, Rebetyn Vigapharma
  • Malta · Monuril
  • Netherlands · Fomicyt, Fosfomycine 1a Pharma
  • Norway · Fosfomycin Infectopharm, Monuril
  • Poland · Afastural, Fosfacin
  • Portugal · Fosfomicina Generis, Fosfomicina Generis Phar
  • Romania · Fomicyt, Fosfomicină Rompharm
  • Sweden · Fosfomycin Infectopharm, Monuril
  • Slovenia · Cisof
  • Slovakia · Fomicyt, Fosfomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7e6d8e4-98b4-47e0-a219-810b861c46ed
GET /v1/drugs/f7e6d8e4-98b4-47e0-a219-810b861c46ed?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1463695200000,\"rev\":1629703199000}",
  "nregistro": "80902",
  "substance": "fosfomicina"
}

See everything about fosfomycin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.